Testicular nonseminoma and seminoma in relation to perinatal characteristics

Journal of the National Cancer Institute

Volumn 88, Issue 13, 1996, Pages 883-889

  Akre, Olof ^a   Ekbom, Anders ^a,b,c   Hsieh, Chung Cheng ^d   Trichopoulos, Dimitrios ^c   Adami, Hans Olov ^b,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b University Hospital   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL BEHAVIOR; NEWBORN JAUNDICE; PERINATAL PERIOD; PLACENTA WEIGHT; RISK FACTOR; SEMINOMA; SOCIOECONOMICS; SWEDEN; TESTIS NONSEMINOMA CANCER;

BIRTH WEIGHT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GERMINOMA; GESTATIONAL AGE; HUMANS; HYPERBILIRUBINEMIA; JAUNDICE; MALE; MATERNAL AGE; MEDICAL RECORD LINKAGE; ODDS RATIO; ORGAN SIZE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES; RISK; RISK FACTORS; SEMINOMA; SOCIOECONOMIC FACTORS; SWEDEN; TESTICULAR NEOPLASMS;

EID: 0029957120     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.13.883     Document Type: Article

References (40)

1. Adami HO, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Testicular cancer in nine northern European countries. Int J Cancer 1994;59:33-8.
2. Whelan SL, Parkin DM, Masuyer E, editors. Patterns of cancer in five continents. IARC Sci Publ 1990;102:1-159.
3. Tomatis L, Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, et al., editors. Cancer: causes, occurrence and control. IARC Sci Publ 1990; 100:1-352.
4. Forman D, Gallagher R, Moller H, Swerdlow TJ. Aetiology and epidemiology of testicular cancer: report of consensus group. In: EORTC Genitourinary Group Monograph 7: prostate cancer and testicular cancer. New York: Wiley-Liss, Inc., 1990:245-53.
5. Senturia YD. The epidemiology of testicular cancer. Br J Urol 1987; 60:285-91.
6. Bergstrom R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996;88:727-33.
7. Davies JM. Testicular cancer in England and Wales: some epidemiological aspects. Lancet 1981;1:928-32.
8. Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer 1986;53:501-5.
9. Grumet RF, MacMahon B. Trends in mortality from neoplasms of the testis. Cancer 1958;11:790-7.
10. Schottenfeld D, Warshauer ME. Testis. In: Schottenfeld D, Fraumeni FJ Jr, editors Cancer epidemiology and prevention. Philadelphia: Saunders, 1982:947-57.
11. Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, Horm JW, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 1987;79:701-70.
12. Pinczowski D, McLaughlin JK, Lackgren G, Adami HO, Persson I. Occurrence of testicular cancer in patients operated for cryptorchidism and inguinal hernia. J Urol 1991;146:1291-4.
13. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group [see comment citation in Medline]. BMJ 1994;308:1393-9.
14. Brown LM, Pottern LM, Hoover RN. Testicular cancer in young men: the search for causes of the epidemic increase in the United States. J Epidemiol Community Health 1987;41:349-54.
15. Haughey BP, Graham S, Brasure J, Zielezny M, Sufrin G, Burnett WS. The epidemiology of testicular cancer in upstate New York. Am J Epidemiol 1989;130:25-36.
16. Giwercman A, Grindsted J, Hansen B, Jensen OM, Skakkebaek NE. Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol 1987;138:1214-6.
17. Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980;112:232-46.
18. Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol 1986; 124:39-52.
19. Swerdlow AJ, Huttly SR, Smith PG. Testicular cancer and antecedent diseases. Br J Cancer 1987;55:97-103.
20. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-5.
21. Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer 1979;23:598-602.
22. Walker AH, Bernstein L, Warren DW, Warner NE, Zheng X, Henderson BE. The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice. Br J Cancer 1990;62:599-602.
23. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? [see comment citations in Medline]. Lancet 1993;341:1392-5.
24. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993;23:8-15.
25. Brown LM, Pottern LM, Hoover RN. Prenatal and perinatal risk factors for testicular cancer. Cancer Res 1986;46:4812-6.
26. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk [see comment citations in Medline]. Lancet 1992;340:1015-8.
27. Prener A, Hsieh CC, Engholm G, Trichopoulos D, Jensen OM. Birth order and risk of testicular cancer. Cancer Causes Control 1992;3:265-72.
28. Swerdlow AJ, Huttly SR, Smith PG. Prenatal and familial associations of testicular cancer. Br J Cancer 1987;55:571-7.
29. Pearce N, Sheppaid RA, Howard IK, Fraser J, Lilley BM. Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 1987;59:1677-82.
30. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person number systems of Sweden, Norway, Denmark and Israel. Hyattsville (MD): DHHS Publ No. (PHS)80-1358. Vital and health statistics, series 2, No. 84:5-11, National Center for Health Statistics, 1980.
31. Ekbom A, Zack M, Adami HO, Helmick C. Is there clustering of inflammatory bowel disease at birth? Am J Epidemiol 1991;134:876-86.
32. Breslow NE, Day NE. Statistical methods in cancer research. Volume I. The analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
33. Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D. Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1990;1:119-24.
34. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985;74:741-5.
35. Davies TW, Williams DR, Whitaker RH. Risk factors for undescended testis. Int J Epidemiol 1986;15:197-201.
36. Walker AM. Observation and inference. Chapter 9. Chestnut Hill (MA): Epidemiology Resources Inc., 1991.
37. Baker PR, Wilton JC, Jones CE, Stenzel DJ, Watson N, Smith GJ. Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells. Br J Cancer 1992;65:566-72.
38. Taina E, Hanninen P, Gronroos M. Viral infections in pregnancy. Acta Obstet Gynecol Scand 1985;64:167-73.
39. Mueller N, Hinkula J, Wahren B. Elevated antibody titers against cytomegalovirus among patients with testicular cancer. Int J Cancer 1988;41:399-403.
40. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami HO. Perinatal characteristics and adult mammographie patterns. Int J Cancer 1995;61: 177-80.